Spine BioPharma Funding: $13M Raised, Series B (2022)
Spine BioPharma is based in New York, NY. It has raised $13M in total funding. Latest round: Series B. Backed by Viscogliosi Bros., LLC.
Spine BioPharma funding overview
Spine BioPharma is based in New York, NY. Spine BioPharma has raised $13M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in March 2022. The round record for Spine BioPharma runs through 2022; nothing later has been disclosed. Investors on record include Viscogliosi Bros., LLC.
Spine BioPharma at a glance
Total raised
$13M
Latest round
Series B
Latest round date
March 2022
Headquarters
New York, NY
Notable investors
Viscogliosi Bros., LLC
Frequently asked about Spine BioPharma funding
How much has Spine BioPharma raised?
Spine BioPharma has raised $13M in total disclosed funding across the rounds on record.
Who has invested in Spine BioPharma?
Viscogliosi Bros., LLC are named among the investors backing Spine BioPharma.
What was the latest Spine BioPharma funding round?
The most recent disclosed round is a Series B, announced in March 2022.
Where is Spine BioPharma based?
Spine BioPharma is based in New York, NY.
When did Spine BioPharma last raise?
The last disclosed Spine BioPharma round closed in March 2022 at Series B.
Spine BioPharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
Spine BioPharma funding history
5 disclosed rounds on record, including 4 reported through SEC Form D filings.
Filed June 2026 — Private financing. $384,798 sold of a $8.5M offering. 3 investors reported. SEC Form D filing
Filed December 2024 — Private financing. $13.5M sold of a $23.5M offering. 10 investors reported. SEC Form D filing
Filed August 2023 — Private financing. $2.4M sold of a $15M offering. 3 investors reported. SEC Form D filing
Filed February 2023 — Private financing. $13M sold of a $13M offering. 8 investors reported. SEC Form D filing
March 2022 — Series B. $13M.
SEC Form D filings report the amount sold against a stated offering size, which can differ from press-reported round totals, and they do not name the round — those entries appear as Private financing.
